Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China · Delayed Price · Currency is CNY 36.08
+1.09 (3.12%)
At close: Jul 25, 2025, 2:57 PM CST
SHE:301263 Market Cap
SHE:301263 has a market cap or net worth of 15.28 billion as of July 25, 2025. Its market cap has increased by 187.95% in one year.
Market Cap
15.28B
Enterprise Value
15.00B
Revenue
716.59M
Ranking
n/a
PE Ratio
162.83
Stock Price
36.08
Market Cap Chart
Since March 29, 2022, SHE:301263's market cap has increased from 8.26B to 15.28B, an increase of 85.01%. That is a compound annual growth rate of 20.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 15.28B | 140.69% |
| Dec 31, 2024 | 6.35B | -8.63% |
| Dec 29, 2023 | 6.95B | -9.56% |
| Dec 30, 2022 | 7.68B | -6.98% |
| Mar 29, 2022 | 8.26B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 383.73B |
| Shenzhen Mindray Bio-Medical Electronics | 280.66B |
| WuXi AppTec | 247.99B |
| Sichuan Biokin Pharmaceutical | 124.67B |
| Aier Eye Hospital Group | 124.19B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.16B |
| Shanghai United Imaging Healthcare | 112.55B |
| Yunnan Baiyao Group Co.,Ltd | 101.77B |